We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-21.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$2.63B
AUM Growth
-$1.11B
Cap. Flow
-$123M
Cap. Flow %
-4.66%
Top 10 Hldgs %
51.48%
Holding
146
New
29
Increased
20
Reduced
29
Closed
45

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$123M
2
AMRN
Amarin Corp
AMRN
+$77.8M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$47.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$41M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$39M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$72M
2
CORI
Corium International, Inc.
CORI
+$60.5M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
+$43.4M
4
ISRG icon
Intuitive Surgical
ISRG
+$41.6M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$37.2M

Sector Composition

Rank Sector Weight
1 Healthcare 97.94%
2 Miscellaneous 1.24%
3 Consumer Staples 0.68%
4 Financials 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
126
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-5,627
Closed -$711K
TRHC
127
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-14,663
Closed -$1.19M
RETA
128
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-9,677
Closed -$791K
ABMD
129
DELISTED
Abiomed Inc
ABMD
– –
-23,800
Closed -$10.7M
CLVS
130
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-150,000
Closed -$4.41M
PTE
131
DELISTED
PolarityTE, Inc. Common Stock
PTE
– –
-13,473
Closed -$6.43M
ODT
132
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
– –
-100,000
Closed -$1.94M
ADMS
133
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-422,015
Closed -$8.45M
ACHN
134
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-1,000,000
Closed -$3.68M
NVTR
135
DELISTED
Nuvectra Corporation Common Stock
NVTR
– –
-135,000
Closed -$2.97M
TSRO
136
DELISTED
TESARO, Inc.
TSRO
– –
-200,000
Closed -$7.8M
ECYT
137
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-2,441,700
Closed -$43.4M
ONSIW
138
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
– –
-420,875
Closed -$6K
CORI
139
DELISTED
Corium International, Inc.
CORI
– –
-6,357,133
Closed -$60.5M
BHVN
140
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-990,943
Closed -$37.2M
2 3 4 5
6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Perceptive Advisors held 146 positions worth $2.63B, down 30% from $3.74B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Perceptive Advisors withdrew a net $123M in Q4 2018, closing 45 positions and reducing 29 holdings. Its most notable exit was Corium International, Inc., an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Solid Biosciences worth $105M.

  • Perceptive Advisors's largest Q4 2018 buy was Solid Biosciences: 261,815 shares worth $105M.
  • Perceptive Advisors added most to Amarin Corp in Q4 2018, an estimated $77.8M increase.
  • Perceptive Advisors's biggest Q4 2018 reduction was Alnylam Pharmaceuticals, cutting an estimated $72M.
  • Perceptive Advisors fully exited Corium International, Inc. in Q4 2018, selling an estimated $60.5M.
  • Perceptive Advisors's ten largest holdings make up 51% of its $2.63B portfolio in Q4 2018.
  • Perceptive Advisors opened 29 new positions and closed 45 in Q4 2018.
  • Perceptive Advisors's portfolio value fell 30% quarter-over-quarter to $2.63B.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.